The present invention relates to methods for inhibiting the activity of human kallikrein 7 (KLK7) (also known as serine protease stratum corneum chymotryptic enzyme, SCCE). The invention further relates to the use of KLK7 inhibitors of Formula I for the treatment and prevention of diseases, more specifically for the treatment and prevention of skin diseases. The invention also provides new compounds demonstrated to be inhibitors of KLK7.
本发明涉及抑制人体卡利肌酶7(KLK7)(也称为
丝氨酸蛋白酶角质层胰
蛋白酶,SCCE)活性的方法。本发明还涉及使用式I的KLK7
抑制剂治疗和预防疾病,更具体地用于治疗和预防皮肤疾病。本发明还提供了新的化合物,证明其是KLK7的
抑制剂。